Home › Chronic Myelomonocytic Leukemia › Alabama › Birmingham
Chronic Myelomonocytic Leukemia clinical trials in Birmingham, AL
4 studies for Chronic Myelomonocytic Leukemia are looking for participants at sites in and around Birmingham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
RecruitingPhase 2
- The University of Alabama at Birmingham, Birmingham
Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
RecruitingObservational study
- AllerVie Clinical Research, Birmingham
- O'Neal Comprehensive Cancer Center at the UAB, Birmingham
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
RecruitingPhase 2
- University of Alabama Birmingham, Birmingham
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
RecruitingPhase 1/2
- The Kirklin Clinic of UAB Hospital, Birmingham
Chronic Myelomonocytic Leukemia trials in other cities
- Houston, TX16 studies
- Seattle, WA10 studies
- Boston, MA7 studies
- New York City, NY6 studies
- Mountain View, CA6 studies
- Baldwin Park, CA6 studies
- Rochester, MN6 studies
- Durham, NC5 studies
- Miami, FL4 studies
- Atlanta, GA4 studies
- Tampa, FL4 studies
- Columbus, OH4 studies
Other studies in Birmingham
- Cancer (all types)30 studies
- Breast Cancer24 studies
- Obesity23 studies
- Ovarian Cancer23 studies
- Non-Small Cell Lung Cancer22 studies
- Acute Myeloid Leukemia21 studies
- Multiple Myeloma18 studies
- COPD17 studies
- Cardiovascular Disease17 studies
- Overweight16 studies
- Endometrial Cancer16 studies
- Type 2 Diabetes16 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.